nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—OPRD1—Amitriptyline—migraine	0.204	0.272	CbGbCtD
Oxymorphone—OPRK1—Amitriptyline—migraine	0.171	0.227	CbGbCtD
Oxymorphone—OPRM1—Amitriptyline—migraine	0.15	0.2	CbGbCtD
Oxymorphone—CYP2D6—Timolol—migraine	0.0404	0.0539	CbGbCtD
Oxymorphone—CYP2D6—Propranolol—migraine	0.036	0.048	CbGbCtD
Oxymorphone—CYP2D6—Amitriptyline—migraine	0.0312	0.0416	CbGbCtD
Oxymorphone—CYP2D6—Verapamil—migraine	0.0247	0.033	CbGbCtD
Oxymorphone—CYP3A4—Propranolol—migraine	0.0229	0.0306	CbGbCtD
Oxymorphone—CYP3A4—Amitriptyline—migraine	0.0198	0.0264	CbGbCtD
Oxymorphone—CYP3A4—Valproic Acid—migraine	0.0181	0.0241	CbGbCtD
Oxymorphone—CYP3A4—Topiramate—migraine	0.0163	0.0217	CbGbCtD
Oxymorphone—CYP3A4—Verapamil—migraine	0.0157	0.021	CbGbCtD
Oxymorphone—Naloxone—ESR1—migraine	0.00058	1	CrCbGaD
Oxymorphone—Somnolence—Verapamil—migraine	0.00043	0.00203	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Propranolol—migraine	0.00043	0.00203	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000428	0.0114	CbGpPWpGaD
Oxymorphone—Hallucination—Timolol—migraine	0.000428	0.00202	CcSEcCtD
Oxymorphone—Dizziness—Amitriptyline—migraine	0.000427	0.00202	CcSEcCtD
Oxymorphone—Dyspepsia—Verapamil—migraine	0.000426	0.00201	CcSEcCtD
Oxymorphone—Abdominal distension—Topiramate—migraine	0.000423	0.002	CcSEcCtD
Oxymorphone—Mental disorder—Valproic Acid—migraine	0.000423	0.002	CcSEcCtD
Oxymorphone—Malnutrition—Valproic Acid—migraine	0.00042	0.00199	CcSEcCtD
Oxymorphone—Urticaria—Propranolol—migraine	0.000418	0.00197	CcSEcCtD
Oxymorphone—Fatigue—Verapamil—migraine	0.000417	0.00197	CcSEcCtD
Oxymorphone—Abdominal pain—Propranolol—migraine	0.000416	0.00196	CcSEcCtD
Oxymorphone—Body temperature increased—Propranolol—migraine	0.000416	0.00196	CcSEcCtD
Oxymorphone—Visual impairment—Timolol—migraine	0.000414	0.00196	CcSEcCtD
Oxymorphone—Flatulence—Valproic Acid—migraine	0.000414	0.00196	CcSEcCtD
Oxymorphone—Constipation—Verapamil—migraine	0.000414	0.00195	CcSEcCtD
Oxymorphone—Pain—Verapamil—migraine	0.000414	0.00195	CcSEcCtD
Oxymorphone—Tension—Valproic Acid—migraine	0.000412	0.00195	CcSEcCtD
Oxymorphone—Vomiting—Amitriptyline—migraine	0.000411	0.00194	CcSEcCtD
Oxymorphone—Sweating increased—Topiramate—migraine	0.00041	0.00194	CcSEcCtD
Oxymorphone—Nervousness—Valproic Acid—migraine	0.000408	0.00193	CcSEcCtD
Oxymorphone—Bradycardia—Gabapentin—migraine	0.000407	0.00192	CcSEcCtD
Oxymorphone—Dermatitis—Amitriptyline—migraine	0.000407	0.00192	CcSEcCtD
Oxymorphone—OPRK1—G alpha (i) signalling events—HTR1D—migraine	0.000405	0.0107	CbGpPWpGaD
Oxymorphone—Headache—Amitriptyline—migraine	0.000405	0.00191	CcSEcCtD
Oxymorphone—Eye disorder—Timolol—migraine	0.000402	0.0019	CcSEcCtD
Oxymorphone—Cardiac disorder—Timolol—migraine	0.000399	0.00188	CcSEcCtD
Oxymorphone—Feeling abnormal—Verapamil—migraine	0.000399	0.00188	CcSEcCtD
Oxymorphone—Hallucination—Gabapentin—migraine	0.000398	0.00188	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000398	0.0106	CbGpPWpGaD
Oxymorphone—Vision blurred—Valproic Acid—migraine	0.000396	0.00187	CcSEcCtD
Oxymorphone—Urinary tract disorder—Gabapentin—migraine	0.000395	0.00187	CcSEcCtD
Oxymorphone—Urethral disorder—Gabapentin—migraine	0.000392	0.00185	CcSEcCtD
Oxymorphone—Angiopathy—Timolol—migraine	0.00039	0.00184	CcSEcCtD
Oxymorphone—Immune system disorder—Timolol—migraine	0.000388	0.00183	CcSEcCtD
Oxymorphone—Hypersensitivity—Propranolol—migraine	0.000387	0.00183	CcSEcCtD
Oxymorphone—Mediastinal disorder—Timolol—migraine	0.000387	0.00183	CcSEcCtD
Oxymorphone—Agitation—Valproic Acid—migraine	0.000386	0.00182	CcSEcCtD
Oxymorphone—Visual impairment—Gabapentin—migraine	0.000386	0.00182	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—RAMP1—migraine	0.000384	0.0102	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CALCRL—migraine	0.000384	0.0102	CbGpPWpGaD
Oxymorphone—Urticaria—Verapamil—migraine	0.000384	0.00182	CcSEcCtD
Oxymorphone—Nausea—Amitriptyline—migraine	0.000384	0.00181	CcSEcCtD
Oxymorphone—Weight decreased—Topiramate—migraine	0.00038	0.0018	CcSEcCtD
Oxymorphone—Vertigo—Valproic Acid—migraine	0.000377	0.00178	CcSEcCtD
Oxymorphone—Asthenia—Propranolol—migraine	0.000377	0.00178	CcSEcCtD
Oxymorphone—Pneumonia—Topiramate—migraine	0.000377	0.00178	CcSEcCtD
Oxymorphone—Mental disorder—Timolol—migraine	0.000376	0.00178	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000375	0.00997	CbGpPWpGaD
Oxymorphone—Malnutrition—Timolol—migraine	0.000374	0.00177	CcSEcCtD
Oxymorphone—Eye disorder—Gabapentin—migraine	0.000374	0.00177	CcSEcCtD
Oxymorphone—Cardiac disorder—Gabapentin—migraine	0.000371	0.00175	CcSEcCtD
Oxymorphone—Palpitations—Valproic Acid—migraine	0.000371	0.00175	CcSEcCtD
Oxymorphone—Tension—Timolol—migraine	0.000367	0.00173	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000367	0.00974	CbGpPWpGaD
Oxymorphone—Nervousness—Timolol—migraine	0.000363	0.00172	CcSEcCtD
Oxymorphone—Hypertension—Valproic Acid—migraine	0.000363	0.00171	CcSEcCtD
Oxymorphone—Immune system disorder—Gabapentin—migraine	0.000361	0.00171	CcSEcCtD
Oxymorphone—Mediastinal disorder—Gabapentin—migraine	0.000361	0.0017	CcSEcCtD
Oxymorphone—Diarrhoea—Propranolol—migraine	0.00036	0.0017	CcSEcCtD
Oxymorphone—Chest pain—Valproic Acid—migraine	0.000358	0.00169	CcSEcCtD
Oxymorphone—Anxiety—Valproic Acid—migraine	0.000356	0.00168	CcSEcCtD
Oxymorphone—Hypersensitivity—Verapamil—migraine	0.000356	0.00168	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000355	0.00168	CcSEcCtD
Oxymorphone—Vision blurred—Timolol—migraine	0.000352	0.00167	CcSEcCtD
Oxymorphone—Mental disorder—Gabapentin—migraine	0.000351	0.00166	CcSEcCtD
Oxymorphone—Dry mouth—Valproic Acid—migraine	0.00035	0.00165	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000349	0.00927	CbGpPWpGaD
Oxymorphone—Malnutrition—Gabapentin—migraine	0.000348	0.00165	CcSEcCtD
Oxymorphone—Dizziness—Propranolol—migraine	0.000348	0.00164	CcSEcCtD
Oxymorphone—Asthenia—Verapamil—migraine	0.000347	0.00164	CcSEcCtD
Oxymorphone—Confusional state—Valproic Acid—migraine	0.000346	0.00163	CcSEcCtD
Oxymorphone—Flatulence—Gabapentin—migraine	0.000343	0.00162	CcSEcCtD
Oxymorphone—Oedema—Valproic Acid—migraine	0.000343	0.00162	CcSEcCtD
Oxymorphone—Bradycardia—Topiramate—migraine	0.000343	0.00162	CcSEcCtD
Oxymorphone—Pruritus—Verapamil—migraine	0.000342	0.00162	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—HTR1D—migraine	0.000342	0.00908	CbGpPWpGaD
Oxymorphone—Tension—Gabapentin—migraine	0.000342	0.00161	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000341	0.00906	CbGpPWpGaD
Oxymorphone—Nervousness—Gabapentin—migraine	0.000338	0.0016	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—CALCRL—migraine	0.000337	0.00895	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—RAMP1—migraine	0.000337	0.00895	CbGpPWpGaD
Oxymorphone—Nervous system disorder—Valproic Acid—migraine	0.000336	0.00159	CcSEcCtD
Oxymorphone—Vertigo—Timolol—migraine	0.000336	0.00159	CcSEcCtD
Oxymorphone—Syncope—Timolol—migraine	0.000335	0.00158	CcSEcCtD
Oxymorphone—Hallucination—Topiramate—migraine	0.000335	0.00158	CcSEcCtD
Oxymorphone—Tachycardia—Valproic Acid—migraine	0.000335	0.00158	CcSEcCtD
Oxymorphone—Vomiting—Propranolol—migraine	0.000334	0.00158	CcSEcCtD
Oxymorphone—Skin disorder—Valproic Acid—migraine	0.000333	0.00157	CcSEcCtD
Oxymorphone—Urinary tract disorder—Topiramate—migraine	0.000332	0.00157	CcSEcCtD
Oxymorphone—Hyperhidrosis—Valproic Acid—migraine	0.000331	0.00157	CcSEcCtD
Oxymorphone—Dermatitis—Propranolol—migraine	0.000331	0.00156	CcSEcCtD
Oxymorphone—Diarrhoea—Verapamil—migraine	0.000331	0.00156	CcSEcCtD
Oxymorphone—Palpitations—Timolol—migraine	0.000331	0.00156	CcSEcCtD
Oxymorphone—Urethral disorder—Topiramate—migraine	0.00033	0.00156	CcSEcCtD
Oxymorphone—Loss of consciousness—Timolol—migraine	0.000329	0.00155	CcSEcCtD
Oxymorphone—Vision blurred—Gabapentin—migraine	0.000328	0.00155	CcSEcCtD
Oxymorphone—Anorexia—Valproic Acid—migraine	0.000327	0.00154	CcSEcCtD
Oxymorphone—Visual impairment—Topiramate—migraine	0.000324	0.00153	CcSEcCtD
Oxymorphone—Hypertension—Timolol—migraine	0.000323	0.00153	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000322	0.00854	CbGpPWpGaD
Oxymorphone—Hypotension—Valproic Acid—migraine	0.00032	0.00151	CcSEcCtD
Oxymorphone—Agitation—Gabapentin—migraine	0.00032	0.00151	CcSEcCtD
Oxymorphone—Dizziness—Verapamil—migraine	0.00032	0.00151	CcSEcCtD
Oxymorphone—Chest pain—Timolol—migraine	0.000318	0.0015	CcSEcCtD
Oxymorphone—Anxiety—Timolol—migraine	0.000317	0.0015	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000317	0.00843	CbGpPWpGaD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000316	0.00149	CcSEcCtD
Oxymorphone—Eye disorder—Topiramate—migraine	0.000315	0.00149	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—NPS—migraine	0.000314	0.00834	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—TAC1—migraine	0.000314	0.00834	CbGpPWpGaD
Oxymorphone—Vertigo—Gabapentin—migraine	0.000313	0.00148	CcSEcCtD
Oxymorphone—Cardiac disorder—Topiramate—migraine	0.000312	0.00148	CcSEcCtD
Oxymorphone—Flushing—Topiramate—migraine	0.000312	0.00148	CcSEcCtD
Oxymorphone—Syncope—Gabapentin—migraine	0.000312	0.00148	CcSEcCtD
Oxymorphone—Nausea—Propranolol—migraine	0.000312	0.00148	CcSEcCtD
Oxymorphone—Dry mouth—Timolol—migraine	0.000311	0.00147	CcSEcCtD
Oxymorphone—Insomnia—Valproic Acid—migraine	0.00031	0.00147	CcSEcCtD
Oxymorphone—Palpitations—Gabapentin—migraine	0.000308	0.00145	CcSEcCtD
Oxymorphone—Confusional state—Timolol—migraine	0.000308	0.00145	CcSEcCtD
Oxymorphone—Vomiting—Verapamil—migraine	0.000307	0.00145	CcSEcCtD
Oxymorphone—Loss of consciousness—Gabapentin—migraine	0.000306	0.00145	CcSEcCtD
Oxymorphone—Dyspnoea—Valproic Acid—migraine	0.000306	0.00144	CcSEcCtD
Oxymorphone—Angiopathy—Topiramate—migraine	0.000305	0.00144	CcSEcCtD
Oxymorphone—Oedema—Timolol—migraine	0.000305	0.00144	CcSEcCtD
Oxymorphone—Somnolence—Valproic Acid—migraine	0.000305	0.00144	CcSEcCtD
Oxymorphone—Dermatitis—Verapamil—migraine	0.000305	0.00144	CcSEcCtD
Oxymorphone—Immune system disorder—Topiramate—migraine	0.000304	0.00144	CcSEcCtD
Oxymorphone—Mediastinal disorder—Topiramate—migraine	0.000303	0.00143	CcSEcCtD
Oxymorphone—Headache—Verapamil—migraine	0.000303	0.00143	CcSEcCtD
Oxymorphone—Dyspepsia—Valproic Acid—migraine	0.000302	0.00143	CcSEcCtD
Oxymorphone—Convulsion—Gabapentin—migraine	0.000302	0.00143	CcSEcCtD
Oxymorphone—Hypertension—Gabapentin—migraine	0.000301	0.00142	CcSEcCtD
Oxymorphone—Shock—Timolol—migraine	0.0003	0.00142	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—EDNRA—migraine	0.0003	0.00796	CbGpPWpGaD
Oxymorphone—Nervous system disorder—Timolol—migraine	0.000299	0.00141	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000299	0.00794	CbGpPWpGaD
Oxymorphone—Decreased appetite—Valproic Acid—migraine	0.000298	0.00141	CcSEcCtD
Oxymorphone—Chest pain—Gabapentin—migraine	0.000297	0.0014	CcSEcCtD
Oxymorphone—Skin disorder—Timolol—migraine	0.000297	0.0014	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Valproic Acid—migraine	0.000296	0.0014	CcSEcCtD
Oxymorphone—Fatigue—Valproic Acid—migraine	0.000296	0.0014	CcSEcCtD
Oxymorphone—Anxiety—Gabapentin—migraine	0.000296	0.0014	CcSEcCtD
Oxymorphone—Hyperhidrosis—Timolol—migraine	0.000295	0.00139	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000295	0.00784	CbGpPWpGaD
Oxymorphone—Mental disorder—Topiramate—migraine	0.000295	0.00139	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000294	0.00139	CcSEcCtD
Oxymorphone—Pain—Valproic Acid—migraine	0.000293	0.00139	CcSEcCtD
Oxymorphone—Constipation—Valproic Acid—migraine	0.000293	0.00139	CcSEcCtD
Oxymorphone—Malnutrition—Topiramate—migraine	0.000293	0.00138	CcSEcCtD
Oxymorphone—Anorexia—Timolol—migraine	0.000291	0.00137	CcSEcCtD
Oxymorphone—Dry mouth—Gabapentin—migraine	0.00029	0.00137	CcSEcCtD
Oxymorphone—Flatulence—Topiramate—migraine	0.000289	0.00136	CcSEcCtD
Oxymorphone—Tension—Topiramate—migraine	0.000288	0.00136	CcSEcCtD
Oxymorphone—Nausea—Verapamil—migraine	0.000287	0.00136	CcSEcCtD
Oxymorphone—Confusional state—Gabapentin—migraine	0.000287	0.00135	CcSEcCtD
Oxymorphone—Hypotension—Timolol—migraine	0.000285	0.00135	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—CALCRL—migraine	0.000285	0.00757	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—RAMP1—migraine	0.000285	0.00757	CbGpPWpGaD
Oxymorphone—Nervousness—Topiramate—migraine	0.000285	0.00134	CcSEcCtD
Oxymorphone—Oedema—Gabapentin—migraine	0.000284	0.00134	CcSEcCtD
Oxymorphone—Feeling abnormal—Valproic Acid—migraine	0.000283	0.00134	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Valproic Acid—migraine	0.00028	0.00132	CcSEcCtD
Oxymorphone—Shock—Gabapentin—migraine	0.00028	0.00132	CcSEcCtD
Oxymorphone—OPRD1—G alpha (i) signalling events—HTR1B—migraine	0.00028	0.00742	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—HTR1D—migraine	0.000279	0.00742	CbGpPWpGaD
Oxymorphone—Nervous system disorder—Gabapentin—migraine	0.000279	0.00132	CcSEcCtD
Oxymorphone—Tachycardia—Gabapentin—migraine	0.000277	0.00131	CcSEcCtD
Oxymorphone—Vision blurred—Topiramate—migraine	0.000276	0.0013	CcSEcCtD
Oxymorphone—Skin disorder—Gabapentin—migraine	0.000276	0.0013	CcSEcCtD
Oxymorphone—Insomnia—Timolol—migraine	0.000276	0.0013	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—TAC1—migraine	0.000275	0.00732	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—NPS—migraine	0.000275	0.00732	CbGpPWpGaD
Oxymorphone—Hyperhidrosis—Gabapentin—migraine	0.000275	0.0013	CcSEcCtD
Oxymorphone—Urticaria—Valproic Acid—migraine	0.000272	0.00129	CcSEcCtD
Oxymorphone—Dyspnoea—Timolol—migraine	0.000272	0.00129	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000272	0.00722	CbGpPWpGaD
Oxymorphone—Somnolence—Timolol—migraine	0.000271	0.00128	CcSEcCtD
Oxymorphone—Abdominal pain—Valproic Acid—migraine	0.000271	0.00128	CcSEcCtD
Oxymorphone—Body temperature increased—Valproic Acid—migraine	0.000271	0.00128	CcSEcCtD
Oxymorphone—Anorexia—Gabapentin—migraine	0.000271	0.00128	CcSEcCtD
Oxymorphone—Agitation—Topiramate—migraine	0.000269	0.00127	CcSEcCtD
Oxymorphone—OPRD1—G alpha (i) signalling events—HTR1A—migraine	0.000269	0.00715	CbGpPWpGaD
Oxymorphone—Dyspepsia—Timolol—migraine	0.000269	0.00127	CcSEcCtD
Oxymorphone—Hypotension—Gabapentin—migraine	0.000266	0.00125	CcSEcCtD
Oxymorphone—Decreased appetite—Timolol—migraine	0.000265	0.00125	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Timolol—migraine	0.000264	0.00125	CcSEcCtD
Oxymorphone—Vertigo—Topiramate—migraine	0.000263	0.00124	CcSEcCtD
Oxymorphone—Fatigue—Timolol—migraine	0.000263	0.00124	CcSEcCtD
Oxymorphone—Syncope—Topiramate—migraine	0.000263	0.00124	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—EDNRA—migraine	0.000263	0.00698	CbGpPWpGaD
Oxymorphone—Pain—Timolol—migraine	0.000261	0.00123	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—HTR2B—migraine	0.00026	0.0069	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000259	0.00689	CbGpPWpGaD
Oxymorphone—Palpitations—Topiramate—migraine	0.000259	0.00122	CcSEcCtD
Oxymorphone—Loss of consciousness—Topiramate—migraine	0.000258	0.00122	CcSEcCtD
Oxymorphone—Insomnia—Gabapentin—migraine	0.000257	0.00121	CcSEcCtD
Oxymorphone—Convulsion—Topiramate—migraine	0.000254	0.0012	CcSEcCtD
Oxymorphone—Dyspnoea—Gabapentin—migraine	0.000253	0.0012	CcSEcCtD
Oxymorphone—Hypertension—Topiramate—migraine	0.000253	0.0012	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000253	0.00671	CbGpPWpGaD
Oxymorphone—Somnolence—Gabapentin—migraine	0.000253	0.00119	CcSEcCtD
Oxymorphone—Hypersensitivity—Valproic Acid—migraine	0.000253	0.00119	CcSEcCtD
Oxymorphone—Feeling abnormal—Timolol—migraine	0.000252	0.00119	CcSEcCtD
Oxymorphone—Dyspepsia—Gabapentin—migraine	0.00025	0.00118	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00025	0.00663	CbGpPWpGaD
Oxymorphone—Gastrointestinal pain—Timolol—migraine	0.00025	0.00118	CcSEcCtD
Oxymorphone—Chest pain—Topiramate—migraine	0.000249	0.00118	CcSEcCtD
Oxymorphone—Anxiety—Topiramate—migraine	0.000249	0.00117	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000248	0.00117	CcSEcCtD
Oxymorphone—Decreased appetite—Gabapentin—migraine	0.000247	0.00117	CcSEcCtD
Oxymorphone—Asthenia—Valproic Acid—migraine	0.000246	0.00116	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Gabapentin—migraine	0.000245	0.00116	CcSEcCtD
Oxymorphone—OPRK1—G alpha (i) signalling events—HTR1B—migraine	0.000245	0.00651	CbGpPWpGaD
Oxymorphone—Fatigue—Gabapentin—migraine	0.000245	0.00116	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—HTR1D—migraine	0.000245	0.00651	CbGpPWpGaD
Oxymorphone—Dry mouth—Topiramate—migraine	0.000244	0.00115	CcSEcCtD
Oxymorphone—Constipation—Gabapentin—migraine	0.000243	0.00115	CcSEcCtD
Oxymorphone—Pain—Gabapentin—migraine	0.000243	0.00115	CcSEcCtD
Oxymorphone—Pruritus—Valproic Acid—migraine	0.000243	0.00115	CcSEcCtD
Oxymorphone—Urticaria—Timolol—migraine	0.000243	0.00115	CcSEcCtD
Oxymorphone—Abdominal pain—Timolol—migraine	0.000241	0.00114	CcSEcCtD
Oxymorphone—Body temperature increased—Timolol—migraine	0.000241	0.00114	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000241	0.00641	CbGpPWpGaD
Oxymorphone—Confusional state—Topiramate—migraine	0.000241	0.00114	CcSEcCtD
Oxymorphone—Oedema—Topiramate—migraine	0.000239	0.00113	CcSEcCtD
Oxymorphone—OPRK1—G alpha (i) signalling events—HTR1A—migraine	0.000236	0.00627	CbGpPWpGaD
Oxymorphone—Shock—Topiramate—migraine	0.000235	0.00111	CcSEcCtD
Oxymorphone—Diarrhoea—Valproic Acid—migraine	0.000235	0.00111	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000235	0.00623	CbGpPWpGaD
Oxymorphone—Nervous system disorder—Topiramate—migraine	0.000235	0.00111	CcSEcCtD
Oxymorphone—Feeling abnormal—Gabapentin—migraine	0.000234	0.00111	CcSEcCtD
Oxymorphone—Tachycardia—Topiramate—migraine	0.000233	0.0011	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—TAC1—migraine	0.000233	0.00618	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—NPS—migraine	0.000233	0.00618	CbGpPWpGaD
Oxymorphone—Gastrointestinal pain—Gabapentin—migraine	0.000232	0.0011	CcSEcCtD
Oxymorphone—Skin disorder—Topiramate—migraine	0.000232	0.0011	CcSEcCtD
Oxymorphone—Hyperhidrosis—Topiramate—migraine	0.000231	0.00109	CcSEcCtD
Oxymorphone—Anorexia—Topiramate—migraine	0.000228	0.00108	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—HTR2B—migraine	0.000228	0.00605	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000227	0.00604	CbGpPWpGaD
Oxymorphone—Dizziness—Valproic Acid—migraine	0.000227	0.00107	CcSEcCtD
Oxymorphone—Urticaria—Gabapentin—migraine	0.000226	0.00107	CcSEcCtD
Oxymorphone—Hypersensitivity—Timolol—migraine	0.000225	0.00106	CcSEcCtD
Oxymorphone—Body temperature increased—Gabapentin—migraine	0.000225	0.00106	CcSEcCtD
Oxymorphone—Abdominal pain—Gabapentin—migraine	0.000225	0.00106	CcSEcCtD
Oxymorphone—Hypotension—Topiramate—migraine	0.000223	0.00106	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000222	0.0059	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—EDNRA—migraine	0.000222	0.0059	CbGpPWpGaD
Oxymorphone—Asthenia—Timolol—migraine	0.000219	0.00103	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000219	0.00582	CbGpPWpGaD
Oxymorphone—Vomiting—Valproic Acid—migraine	0.000218	0.00103	CcSEcCtD
Oxymorphone—OPRD1—GPCR downstream signaling—RAMP1—migraine	0.000217	0.00577	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CALCRL—migraine	0.000217	0.00577	CbGpPWpGaD
Oxymorphone—Insomnia—Topiramate—migraine	0.000216	0.00102	CcSEcCtD
Oxymorphone—Dermatitis—Valproic Acid—migraine	0.000216	0.00102	CcSEcCtD
Oxymorphone—Pruritus—Timolol—migraine	0.000216	0.00102	CcSEcCtD
Oxymorphone—Headache—Valproic Acid—migraine	0.000215	0.00101	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000214	0.00568	CbGpPWpGaD
Oxymorphone—Dyspnoea—Topiramate—migraine	0.000213	0.00101	CcSEcCtD
Oxymorphone—Somnolence—Topiramate—migraine	0.000213	0.001	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000211	0.00562	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000211	0.00561	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000211	0.0056	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000211	0.0056	CbGpPWpGaD
Oxymorphone—Dyspepsia—Topiramate—migraine	0.000211	0.000995	CcSEcCtD
Oxymorphone—Hypersensitivity—Gabapentin—migraine	0.000209	0.000989	CcSEcCtD
Oxymorphone—Diarrhoea—Timolol—migraine	0.000209	0.000987	CcSEcCtD
Oxymorphone—Decreased appetite—Topiramate—migraine	0.000208	0.000982	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—HTR1B—migraine	0.000207	0.0055	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—HTR1D—migraine	0.000207	0.0055	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000207	0.00549	CbGpPWpGaD
Oxymorphone—Gastrointestinal disorder—Topiramate—migraine	0.000206	0.000975	CcSEcCtD
Oxymorphone—Fatigue—Topiramate—migraine	0.000206	0.000974	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000206	0.00546	CbGpPWpGaD
Oxymorphone—Pain—Topiramate—migraine	0.000205	0.000966	CcSEcCtD
Oxymorphone—Constipation—Topiramate—migraine	0.000205	0.000966	CcSEcCtD
Oxymorphone—Asthenia—Gabapentin—migraine	0.000204	0.000964	CcSEcCtD
Oxymorphone—Nausea—Valproic Acid—migraine	0.000204	0.000962	CcSEcCtD
Oxymorphone—OPRM1—TCR Signaling Pathway—FOS—migraine	0.000204	0.00541	CbGpPWpGaD
Oxymorphone—Dizziness—Timolol—migraine	0.000202	0.000954	CcSEcCtD
Oxymorphone—Pruritus—Gabapentin—migraine	0.000201	0.00095	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000201	0.00534	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—HTR1A—migraine	0.000199	0.0053	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—RAMP1—migraine	0.000197	0.00524	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CALCRL—migraine	0.000197	0.00524	CbGpPWpGaD
Oxymorphone—Feeling abnormal—Topiramate—migraine	0.000197	0.000931	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Topiramate—migraine	0.000196	0.000924	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000195	0.00518	CbGpPWpGaD
Oxymorphone—Diarrhoea—Gabapentin—migraine	0.000194	0.000919	CcSEcCtD
Oxymorphone—Vomiting—Timolol—migraine	0.000194	0.000917	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—HTR2B—migraine	0.000192	0.00511	CbGpPWpGaD
Oxymorphone—Dermatitis—Timolol—migraine	0.000192	0.000908	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000192	0.00511	CbGpPWpGaD
Oxymorphone—Headache—Timolol—migraine	0.000191	0.000903	CcSEcCtD
Oxymorphone—OPRK1—GPCR downstream signaling—CALCRL—migraine	0.000191	0.00506	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—RAMP1—migraine	0.000191	0.00506	CbGpPWpGaD
Oxymorphone—Urticaria—Topiramate—migraine	0.00019	0.000898	CcSEcCtD
Oxymorphone—Body temperature increased—Topiramate—migraine	0.000189	0.000893	CcSEcCtD
Oxymorphone—Abdominal pain—Topiramate—migraine	0.000189	0.000893	CcSEcCtD
Oxymorphone—Dizziness—Gabapentin—migraine	0.000188	0.000888	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000188	0.00498	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000185	0.00492	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000185	0.00492	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000185	0.00491	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000185	0.00491	CbGpPWpGaD
Oxymorphone—Nausea—Timolol—migraine	0.000181	0.000857	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000181	0.00481	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000181	0.00481	CbGpPWpGaD
Oxymorphone—Vomiting—Gabapentin—migraine	0.000181	0.000854	CcSEcCtD
Oxymorphone—Dermatitis—Gabapentin—migraine	0.000179	0.000846	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000179	0.00475	CbGpPWpGaD
Oxymorphone—Headache—Gabapentin—migraine	0.000178	0.000841	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000176	0.00468	CbGpPWpGaD
Oxymorphone—Hypersensitivity—Topiramate—migraine	0.000176	0.000832	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000174	0.00462	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—RAMP1—migraine	0.000173	0.0046	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CALCRL—migraine	0.000173	0.0046	CbGpPWpGaD
Oxymorphone—Asthenia—Topiramate—migraine	0.000172	0.000811	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—HTR1B—migraine	0.000169	0.0045	CbGpPWpGaD
Oxymorphone—Pruritus—Topiramate—migraine	0.000169	0.000799	CcSEcCtD
Oxymorphone—Nausea—Gabapentin—migraine	0.000169	0.000798	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000165	0.00437	CbGpPWpGaD
Oxymorphone—Diarrhoea—Topiramate—migraine	0.000164	0.000773	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—HTR1A—migraine	0.000163	0.00433	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—RAMP1—migraine	0.000161	0.00428	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CALCRL—migraine	0.000161	0.00428	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—TAC1—migraine	0.00016	0.00426	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—NPS—migraine	0.00016	0.00426	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000159	0.00422	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000159	0.00421	CbGpPWpGaD
Oxymorphone—Dizziness—Topiramate—migraine	0.000158	0.000747	CcSEcCtD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR1D—migraine	0.000158	0.00419	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—HTR2C—migraine	0.000157	0.00418	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000157	0.00416	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000156	0.00415	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000156	0.00415	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000153	0.00407	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—EDNRA—migraine	0.000153	0.00407	CbGpPWpGaD
Oxymorphone—Vomiting—Topiramate—migraine	0.000152	0.000718	CcSEcCtD
Oxymorphone—Dermatitis—Topiramate—migraine	0.000151	0.000712	CcSEcCtD
Oxymorphone—Headache—Topiramate—migraine	0.00015	0.000708	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000149	0.00396	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—HTR1B—migraine	0.000148	0.00394	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000148	0.00393	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CALCA—migraine	0.000147	0.00391	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR2B—migraine	0.000147	0.0039	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—RAMP1—migraine	0.000146	0.00388	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CALCRL—migraine	0.000146	0.00388	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR1D—migraine	0.000143	0.00381	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—HTR1A—migraine	0.000143	0.00379	CbGpPWpGaD
Oxymorphone—Nausea—Topiramate—migraine	0.000142	0.000671	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—TAC1—migraine	0.000141	0.00374	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—NPS—migraine	0.000141	0.00374	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR1D—migraine	0.000138	0.00368	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—HTR2C—migraine	0.000138	0.00366	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—HTR7—migraine	0.000138	0.00366	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—EDNRA—migraine	0.000134	0.00356	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000134	0.00356	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR2B—migraine	0.000133	0.00354	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00013	0.00345	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CALCA—migraine	0.000129	0.00343	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR2B—migraine	0.000129	0.00342	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000127	0.00337	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR1D—migraine	0.000126	0.00334	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—HTR1B—migraine	0.000125	0.00333	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—HTR7—migraine	0.000121	0.00321	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—HTR1A—migraine	0.000121	0.00321	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—NPS—migraine	0.000119	0.00316	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—TAC1—migraine	0.000119	0.00316	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR1D—migraine	0.000117	0.00311	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR2B—migraine	0.000117	0.0031	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—HTR2C—migraine	0.000117	0.0031	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAMP1—migraine	0.000117	0.0031	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CALCRL—migraine	0.000117	0.0031	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—EDNRA—migraine	0.000113	0.00301	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000111	0.00295	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00011	0.00291	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CALCA—migraine	0.000109	0.0029	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR2B—migraine	0.000109	0.00289	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR1D—migraine	0.000106	0.00282	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CALCRL—migraine	0.000102	0.00271	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAMP1—migraine	0.000102	0.00271	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—HTR7—migraine	0.000102	0.00271	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR2B—migraine	9.88e-05	0.00262	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—HTR2A—migraine	9.65e-05	0.00256	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR1B—migraine	9.56e-05	0.00254	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.39e-05	0.0025	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR1A—migraine	9.21e-05	0.00245	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—TAC1—migraine	9.07e-05	0.00241	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—NPS—migraine	9.07e-05	0.00241	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR2C—migraine	8.89e-05	0.00236	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR1B—migraine	8.69e-05	0.00231	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—EDNRA—migraine	8.65e-05	0.0023	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CALCRL—migraine	8.64e-05	0.00229	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAMP1—migraine	8.64e-05	0.00229	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR1D—migraine	8.47e-05	0.00225	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—HTR2A—migraine	8.46e-05	0.00225	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR1B—migraine	8.39e-05	0.00223	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR1A—migraine	8.36e-05	0.00222	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CALCA—migraine	8.33e-05	0.00221	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—NPS—migraine	8.23e-05	0.00219	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—TAC1—migraine	8.23e-05	0.00219	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR2C—migraine	8.07e-05	0.00214	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR1A—migraine	8.07e-05	0.00214	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—TAC1—migraine	7.95e-05	0.00211	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—NPS—migraine	7.95e-05	0.00211	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR2B—migraine	7.87e-05	0.00209	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EDNRA—migraine	7.85e-05	0.00209	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR2C—migraine	7.8e-05	0.00207	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR7—migraine	7.79e-05	0.00207	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR1B—migraine	7.62e-05	0.00202	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—EDNRA—migraine	7.58e-05	0.00201	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CALCA—migraine	7.56e-05	0.00201	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR1D—migraine	7.43e-05	0.00197	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR1A—migraine	7.33e-05	0.00195	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CALCA—migraine	7.3e-05	0.00194	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—TAC1—migraine	7.22e-05	0.00192	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—NPS—migraine	7.22e-05	0.00192	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—HTR2A—migraine	7.15e-05	0.0019	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR1B—migraine	7.09e-05	0.00188	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR2C—migraine	7.08e-05	0.00188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR7—migraine	7.07e-05	0.00188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LRP1—migraine	6.93e-05	0.00184	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR2B—migraine	6.9e-05	0.00183	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EDNRA—migraine	6.89e-05	0.00183	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR7—migraine	6.83e-05	0.00181	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR1A—migraine	6.82e-05	0.00181	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—TAC1—migraine	6.72e-05	0.00178	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—NPS—migraine	6.72e-05	0.00178	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CALCA—migraine	6.63e-05	0.00176	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR2C—migraine	6.59e-05	0.00175	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR1B—migraine	6.44e-05	0.00171	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—EDNRA—migraine	6.41e-05	0.0017	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR1D—migraine	6.28e-05	0.00167	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR7—migraine	6.2e-05	0.00165	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR1A—migraine	6.2e-05	0.00165	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CALCA—migraine	6.17e-05	0.00164	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—TAC1—migraine	6.1e-05	0.00162	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—NPS—migraine	6.1e-05	0.00162	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LRP1—migraine	6.08e-05	0.00161	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR2C—migraine	5.98e-05	0.00159	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR2B—migraine	5.83e-05	0.00155	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EDNRA—migraine	5.82e-05	0.00155	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR7—migraine	5.77e-05	0.00153	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CALCA—migraine	5.6e-05	0.00149	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR2A—migraine	5.45e-05	0.00145	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH4—migraine	5.32e-05	0.00141	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR7—migraine	5.24e-05	0.00139	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LRP1—migraine	5.14e-05	0.00136	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR1B—migraine	5.13e-05	0.00136	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR2A—migraine	4.95e-05	0.00132	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR1A—migraine	4.94e-05	0.00131	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NPS—migraine	4.86e-05	0.00129	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PGR—migraine	4.86e-05	0.00129	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TAC1—migraine	4.86e-05	0.00129	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR2A—migraine	4.78e-05	0.00127	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR2C—migraine	4.77e-05	0.00127	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH4—migraine	4.66e-05	0.00124	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EDNRA—migraine	4.64e-05	0.00123	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH3—migraine	4.52e-05	0.0012	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR1B—migraine	4.5e-05	0.0012	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CALCA—migraine	4.47e-05	0.00119	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR2A—migraine	4.34e-05	0.00115	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR1A—migraine	4.33e-05	0.00115	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TAC1—migraine	4.27e-05	0.00113	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PGR—migraine	4.27e-05	0.00113	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NPS—migraine	4.27e-05	0.00113	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR2C—migraine	4.18e-05	0.00111	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR7—migraine	4.18e-05	0.00111	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EDNRA—migraine	4.07e-05	0.00108	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR2A—migraine	4.04e-05	0.00107	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH3—migraine	3.97e-05	0.00105	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH4—migraine	3.94e-05	0.00105	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CALCA—migraine	3.92e-05	0.00104	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR1B—migraine	3.8e-05	0.00101	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR2A—migraine	3.67e-05	0.000975	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR7—migraine	3.66e-05	0.000973	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR1A—migraine	3.66e-05	0.000972	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NPS—migraine	3.6e-05	0.000957	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TAC1—migraine	3.6e-05	0.000957	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PGR—migraine	3.6e-05	0.000957	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFBR2—migraine	3.6e-05	0.000956	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR2C—migraine	3.53e-05	0.000939	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CACNA1A—migraine	3.46e-05	0.000919	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EDNRA—migraine	3.44e-05	0.000913	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH3—migraine	3.35e-05	0.00089	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CALCA—migraine	3.31e-05	0.000879	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFBR2—migraine	3.15e-05	0.000838	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR7—migraine	3.1e-05	0.000822	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR2A—migraine	2.93e-05	0.000777	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFBR2—migraine	2.67e-05	0.000708	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ESR1—migraine	2.6e-05	0.00069	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR2A—migraine	2.57e-05	0.000682	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ESR1—migraine	2.28e-05	0.000605	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CACNA1A—migraine	2.26e-05	0.000601	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR2A—migraine	2.17e-05	0.000576	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ESR1—migraine	1.92e-05	0.000511	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTHFR—migraine	1.14e-05	0.000304	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTHFR—migraine	7.49e-06	0.000199	CbGpPWpGaD
